Torley Helen
SEC insider (Form 3/4/5 filer). CIK 0001528185. PRESIDENT AND CEO at HALOZYME THERAPEUTICS, INC. (HALO). 217 reported Form 4/5 transactions since Sep 2024; latest on Oct 8, 2026. Located in SAN DIEGO, CA.
Companies Torley Helen has filed insider reports for
- HALOZYME THERAPEUTICS, INC. (HALO): Director, Officer, PRESIDENT AND CEO
Torley Helen
CIK: 0001528185
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HALOZYME THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (217 total)
- Oct 8, 2026HALO
HALOZYME THERAPEUTICS, INC.
ExerciseDirect20K shares at avg. $18.41$368K - Oct 8, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect3.1K shares at avg. $108.91$337K - Oct 8, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect200 shares at avg. $110.51$22K - Oct 8, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect4.8K shares at avg. $108.18$520K - Oct 8, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect11.9K shares at avg. $110.00$1.3M - Oct 7, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect900 shares at avg. $112.78$102K - Oct 7, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect8.6K shares at avg. $111.03$955K - Oct 7, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect200 shares at avg. $113.69$23K - Oct 7, 2026HALO
HALOZYME THERAPEUTICS, INC.
ExerciseDirect20K shares at avg. $18.41$368K - Oct 7, 2026HALO
HALOZYME THERAPEUTICS, INC.
SaleDirect10.3K shares at avg. $111.84$1.2M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 8, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Exercise | 20,000 | $18.41 | $368,200 | Direct |
| Oct 8, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 3,090 | $108.91 | $336,526 | Direct |
| Oct 8, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 200 | $110.51 | $22,102 | Direct |
| Oct 8, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 4,810 | $108.18 | $520,341 | Direct |
| Oct 8, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 11,900 | $110.00 | $1,308,941 | Direct |
| Oct 7, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 900 | $112.78 | $101,502 | Direct |
| Oct 7, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 8,600 | $111.03 | $954,867 | Direct |
| Oct 7, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 200 | $113.69 | $22,739 | Direct |
| Oct 7, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Exercise | 20,000 | $18.41 | $368,200 | Direct |
| Oct 7, 2026 | HALO HALOZYME THERAPEUTICS, INC. | Sale | 10,300 | $111.84 | $1,151,942 | Direct |
1-10 of 217 transactions